Edition:
United States

People: Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

15.47USD
3:59pm EST
Change (% chg)

$-0.05 (-0.32%)
Prev Close
$15.52
Open
$15.35
Day's High
$15.56
Day's Low
$15.35
Volume
85,629
Avg. Vol
43,804
52-wk High
$17.88
52-wk Low
$11.33

de Swaan, Tom 

Dr. Tom de Swaan has served as Member of the Supervisory Board of Koninklijke DSM NV since March 29, 2006. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Dr. de Swaan also served as Non-Executive Director of the Board of GlaxoSmithKline Plc. He is Chairman and Chief Executive Officer of Zurich Financial Services, member Supervisory Board of Van Lanschot Bankiers (chairman until 21 December 2015), chairman Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital and chairman Advisory Board Rotterdam School of Management. Dr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. He graduated from University of Amsterdam with a degree in Economics.

Basic Compensation

Total Annual Compensation, EUR 67,500
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 2,454
Fiscal Year Total, EUR 69,954

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Routs

83,750

Feike Sijbesma

2,366,000

Ewald Kist

2,516,500

Geraldine Matchett

1,333,000

Dimitri de Vreeze

1,457,000

Stephan Tanda

1,560,000
As Of  30 Dec 2015